Global informetric perspective studies on translational medical research by unknown
Yao et al. BMC Medical Informatics and Decision Making 2013, 13:77
http://www.biomedcentral.com/1472-6947/13/77RESEARCH ARTICLE Open AccessGlobal informetric perspective studies on
translational medical research
Qiang Yao1†, Peng-Hui Lyu2*†, Fei-Cheng Ma2, Lan Yao1 and Shi-Jing Zhang1*Abstract
Background: Translational medical research literature has increased rapidly in the last few decades and played a
more and more important role during the development of medicine science. The main aim of this study is to
evaluate the global performance of translational medical research during the past few decades.
Methods: Bibliometric, social network analysis, and visualization technologies were used for analyzing translational
medical research performance from the aspects of subject categories, journals, countries, institutes, keywords, and
MeSH terms. Meanwhile, the co-author, co-words and cluster analysis methods were also used to trace popular
topics in translational medical research related work.
Results: Research output suggested a solid development in translational medical research, in terms of increasing
scientific production and research collaboration. We identified the core journals, mainstream subject categories, leading
countries, and institutions in translational medical research. There was an uneven distribution of publications at
authorial, institutional, and national levels. The most commonly used keywords that appeared in the articles were
“translational research”, “translational medicine”, “biomarkers”, “stroke”, “inflammation”, “cancer”, and “breast cancer”.
Conclusions: The subject categories of “Research & Experimental Medicine”, “Medical Laboratory Technology”, and
“General & Internal Medicine” play a key role in translational medical research both in production and in its networks.
Translational medical research and CTS, etc. are core journals of translational research. G7 countries are the leading
nations for translational medical research. Some developing countries, such as P.R China, also play an important role in
the communication of translational research. The USA and its institutions play a dominant role in the production,
collaboration, citations and high quality articles. The research trends in translational medical research involve drug
design and development, pathogenesis and treatment of disease, disease model research, evidence-based research,
and stem and progenitor cells.
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Translational medical research, originated from the con-
cept of B2B (bench-to-bedside), is a class of medical re-
search aiming to eliminate the barriers between laboratory
and clinical research [1]. It converts promising laboratory
discoveries into clinical applications and elucidates clinical
questions with the use of bench work, aiming to facili-
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reproduction in any medium, provided the ordiseases [2,3]. Translational medical research is defined as
“the application of discoveries generated by laboratory re-
search and preclinical studies to the development of clin-
ical trials and studies in humans and a second area of
translational research concerns enhancing the adoption of
best practices” in MeSH [4]. In addition, Elias A.Zerhouni,
the director of the National Institutes of Health (NIH),
put forward the concept of “translational medicine” in the
NIH Roadmap in 2003. The core of the concept is to
transform the basic research achievements of medical
biology into practical theory, technology and methods that
will bridge laboratory and clinical practice [2].
The US National Institutes of Health (NIH) has de-
voted considerable resources to establish translational. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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have developed many translational research training pro-
grams. New medical journals specifically designed to
cover translational science are rising at an astonishing
pace. Yet clear and coherent definitions of translational
medicine are lacking because translational medicine
means different things to different people [5]. To mo-
lecularly based scientists, it means bridging the gap be-
tween basic and clinical sciences, i.e., transforming
knowledge derived through basic science investigation
into improved diagnosis and treatment of patients in a
bench-to-bedside flow of information. To health care de-
livery scientists, translational medicine means translating
knowledge about individuals into populations, to close
the gap in the access and delivery of new treatment op-
tions [5]. The literature today includes a plethora of at-
tempts in various fields to define the term, and many “T’s”
modes in translational medical research such as 2 T, 3 T,
and 4 T modes were formed during its development pe-
riods. The Institute of Medicine Clinical Research Round-
table first described the current terminology and model of
translational research in 2003 as a two-phase process of
research progressing from (1) basic science to clinical sci-
ence, and (2) from clinical science to public health impact.
In this framework, they identified “translational blocks” in
more steps. The obstacles to research progress represent
major challenge areas for obtaining health improvements
from the basic sciences in its field. The first roadblock
(T1) was described by the roundtable as “the transfer of
new understandings of disease mechanisms gained in
laboratory into the development of new methods for diag-
nosis, therapy, prevention and their first testing in
humans.” The roundtable identified the second roadblock
(T2) as “the translation of results from clinical studies into
daily clinical practice and health decision making” [6].
Interestingly, this model was highly aligned with the NIH
definition. The model portrays T2 as one step—the trans-
lation of new knowledge into clinical practice—but the
process is rarely that simple. Westfall et al. redrew the
model including a third step (T3), practice-based research,
which is often necessary before distilled knowledge can be
implemented in practice [7]. Thus, the second phase of
translation was later subdivided to create a model of the
translational phases which include basic science to clinical
science (T1), to clinical practice (T2), and to health im-
provements (T3) [8].
D. Dougherty and P. H. Conway proposed the 3 T’s
Road Map in 2008 [9]: basic biomedical science to clin-
ical efficacy knowledge (T1), to clinical effectiveness
knowledge (T2), and to improved health care quality
and value and population health (T3). Next, translation
2 activities focus on creating more patient-specific evi-
dence of clinical effectiveness (T2), as well as compara-
tive effectiveness to identify “the right treatment for theright patient in a right way at the right time” and
translation-into-practice guidelines and tools for pa-
tients, clinicians, and policy makers. Translation 3 activ-
ities comprise the essential third step along the 3 T’s
road map (T3). Its activities address the “how” of health
care delivery so that evidence-based treatment, preven-
tion, and other interventions are delivered reliably to all
patients in all settings of care and thus improve the
health of individuals and populations. Meanwhile, the
Evaluation Committee of the Association for Clinical Re-
search Training (ACRT) proposed an operational defin-
ition to use in the 3 T’s educational framework [10].
They posited that translational research fosters the multi-
directional integration of basic research, patient-oriented
research, and population-based research, with the long-
term aim of improving public health. In this model, T1 re-
search expedites the movement between basic research
and patient-oriented research that leads to new or im-
proved scientific understanding or standards of care. T2 re-
search facilitates the movement between patient-oriented
research and population-based research that leads to better
patient outcomes, the implementation of best practices,
and improved health status in communities. And T3 re-
search promotes interaction between laboratory-based re-
search and population-based research to stimulate a robust
scientific understanding of human health and disease. This
model offers a framework to guide institutions in develop-
ing processes of program evaluation.
The most current translation model in the literature ex-
pounds the 4 T’s [8]: basic scientific discovery (basic
knowledge) to potential clinical application (theoretical
knowledge) (T1), to evidence-based guidelines (efficacy
knowledge) (T2), to clinical care or intervention (applied
knowledge) (T3), and to the health of a community or
population (public health knowledge) (T4). In this model,
T1 translational research (potential application) is defined
as translation of basic research into a potential clinical ap-
plication. T2 translational research involves efficacy stud-
ies in which new therapies are tested under controlled
environments to provide the link between potential clin-
ical applications and potential evidence-based guidelines.
T3 translational research (effectiveness studies) involves
translation from recommendations or guidelines into
practice. T4 translational research (population-based) in-
volves outcomes assessments at the community or popu-
lation level (public health).
Translational medical research has recently experi-
enced an upsurge in interest and funding worldwide.
The Director of NIH, Dr. Francis Collins, proposed a
new initiative of five thematic areas in 2010, and “Trans-
lating Basic Science Discoveries into New and Better
Treatments” was one of five thematic areas [11]. Many
translational research programs, centers and institutes
have been rapidly established and lots of core journals
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umns [3,12], such as Science Translational medicine re-
search, the American Journal of Translational Research,
Journal of Translational medicine research, Translational
Research and Clinical and Translational Science. More-
over, Clinical and Translational Science Awards (CTSAs),
The Translational Medical Research Award and the
Bedside-to-Bench Award were established to encourage
translational medical research [13]. By 2012, the CTSA
Consortium had expanded to approximately 60 medical
research institutions located throughout the nation,
linking them together to energize the discipline of clinical
and translational science. At the same time, NIH created
its newest National Center for Advancing Translational
Sciences (NCATS) to advance the development, testing,
and implementation of diagnostics and therapeutics across
a wide range of human diseases and conditions. Advan-
cing translational sciences has become an important mis-
sion of NIH. Translational research has also become a
centerpiece of the European Commission for health re-
lated research in 2006, and during which, the United King-
dom invested the most to establish translational research
centers [14]. The Translational Medicine Research Initia-
tive (TMRI) [15], Scottish Translational Medicine Re-
search Collaboration (TMRC) [16] and the Office for
Strategic Co-ordination of Health Research (OSCHR) [17]
were established to facilitate more efficient translation of
health research into health and economic benefits in the
UK. After 2006, many other countries and regions started
to establish translational research center for translational
research. The People's Republic of China has established
more than fifty translational medicine research centers as
of 2012.
Despite the fact that translational medicine has devel-
oped rapidly worldwide in recently, there have been few
attempts to gather data about the worldwide scientific
production of translational medical research. Bibliometric
research has been recently used as a quantitative analysis
method for scientific research evolution in recent years.
The derived statistics that measure the contribution of sci-
entific publications within a given topic could represent
current research trends and be used to identify focuses of
future study [18]. Through a bibliometric research of lit-
erature, the next research trend may be predicted [19]. In
this study, the records of literature are analyzed using sev-
eral aspects of bibliometric methodology. The main body
of this article includes bibliometric analyses in the publish-
ing year, document type, subject categories, publication
distribution, patterns of journals, countries/regions, insti-
tutes and authors [20,21]. In addition, appropriate statis-
tical tests are used in the authors’ keyword yearly to
predict the developing trend of translational medical re-
search. Moreover, citation data will also be used as a
bibliometric tool to indicate the intellectual impact ofthe research output. We are making efforts to address the
following questions regarding the field of translational
medical research:
 Growth trend of global publication output from
1993 to 2012.
 Subject categories of publication and the
relationship between these subject categories.
 Journals of publication identified.
 Countries of publication and international
collaboration.
 Institutes of publication and international
collaboration.
 Authorship and co-authorship of papers.
 Citation analysis of research publications.
 Distribution of keywords, MeSH terms, and hot
topics.
These efforts will provide evidence of the current sta-
tus and trends in translational medical research all over
the world, as well as clues to the impact of this popular
topic, thus helping researchers understand the panorama
of global translational medical research, and predict the
dynamic directions of research.
Data and methodology
Data sources
As a strictly selected abstract database, Web of Science
(WoS, including SCI-E and SSCI) has long been recog-
nized as the most authoritative scientific and technical lit-
erature indexing tool providing data on most important
areas of science and technology research [22]. We col-
lected the publications on translational medical research
using the Web of Science database online version pub-
lished by Thomson Router ISI, operated by Thomson Sci-
entific, Philadelphia, PA, USA [23]. The main advantage of
the ISI journals is that they constitute the most important
(in terms of impact) journals in the world [22,24]. Drawing
upon relevant research experience [25,26], articles were
extracted using text-supplied keywords from the National
Library of Medicine’s Medical Subject Headings thesaurus.
Terms searched were “Translational Medical Research”,
“Translational Medical Research”, “Translational Medi-
cine”, “Translational Medical Science”, “Translational Re-
search”, “Medical Translational Research”, “Knowledge
Translation”, etc. Identification of translational medical re-
search articles was accomplished by searching titles,
author-supplied abstracts, and texts. The search strategy
of WoS was (TS = (“Translat* Medic*” OR “Translat* Re-
search*” OR “Medic* Translat*”) OR SO = (Translat*))
NOT (WC= (Information Science Library Science OR
Education Educational Research OR Education Special
OR Social Issues OR Social Work OR Computer Science
Interdisciplinary Applications OR Social Sciences
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Probability OR Plant Sciences OR Zoology OR Computer
Science Information Systems OR History Philosophy of
Science OR Ethics OR Computer Science Artificial
Intelligence OR Nuclear Science Technology OR Lan-
guage Linguistics OR Linguistics )). The search strategy of
PubMed was “Translational Medical Research”[Mesh] OR
“Translational Medical Research*”[Title/Abstract] OR
“Translational Medicine”[Title/Abstract] OR “Transla-
tional Medical Science*”[Title/Abstract] OR “Translational
Research*”[Title/Abstract] OR “Medical Translatio-
nal Research*”[Title/Abstract] OR “Medical Research,
Translational”[Title/Abstract] OR “Research, Transla-
tional Medical”[Title/Abstract] OR “Medicine, Trans-
lational”[Title/Abstract] OR “Translational Research,
Medical”[Title/Abstract] OR “Research, Medical Translational”
[Title/Abstract] OR “Medical Science*, Translational”[Title/
Abstract] OR“ Research*, Translational”[Title/Abstract] OR
“Knowledge Translation*”[Title/Abstract] OR “Translation*,
Knowledge”[Title/Abstract].
The benefits of using bibliometric search terms are al-
ways debatable. While the identification of the appropriate
terms identifying translational medical research may be a
matter for further studies, we suggest that these terms
provide an adequate balance for the objectives of this in-
vestigation. They are in accordance with previous investi-
gations as discussed in the methodology section. A total of
5500 publications were identified in the SCI and SSCI da-
tabases and 5,452 publications were identified in PubMed
database within all timespans. The impact factor (IF) of
WoS journals in 2012 was determined by Journal Citation
Reports (JCR), which was the latest data available. Papers
originating from England, Scotland, Northern Ireland, and
Wales are grouped under the UK heading, while those
from Hong Kong, Macao, and Taiwan are not included
under the China heading.
Methods
One of the earliest definitions of bibliometric describes it
as “the application of statistical and mathematical methods
to books and other media of communication” [27]. Today,
bibliometric is often used to assess scientific research
through quantitative studies on research publications.
Bibliometric assessments are based on the assumption
that most scientific discoveries and research results are
eventually published in international scientific journals
where they can be read and cited by other researchers
[28]. In this paper, the distribution of the publishing year,
document types, language, subjects, journals, countries,
institutions, times cited frequency of keywords, cluster
analysis as well as collaboration of the WoS papers were
thoroughly examined. The Thomson Data Analyzer
(TDA), VOSviewer and Aureka software were employedto analyze the publications for knowledge mapping. The
Thomson Data Analyzer™ desktop software often offers a
powerful function for managing and extracting scientific data
within databases. It gives a statistical results for research
work [29]. VOSviewer is a computer program that can create
maps based on network data. It can view and explore maps
written in the Java programming language and can operate
on most hardware and operating system platforms.
VOSviewer is primarily intended to be used for analyzing
bibliometric networks [30]. The program can be used to cre-
ate maps of publications, authors, or journals based on a co-
citation network or to create maps of keywords based on a
co-occurrence network. And with Aureka, one can study the
full text of millions of global literature, maximize the top-line
revenue its portfolio generates, and visualize data to reveal
trends and opportunities [31,32].
The term “co-author,” used to denote multiple writers
appearing simultaneously in one paper, also reflects the col-
laboration of different institutes, regions, or countries
[33,34]. The higher the strength of these co-authorships,
the closer the relationship among them is. Collaboration
between countries was determined by the author descrip-
tion, where the term “independent” was assigned if no col-
laboration was presented. “International collaboration” was
assigned to research if it was co-signed with researchers
from more than one country. “Co-words” refers to the
phenomenon that two or more keywords occur simultan-
eously in one article or one field, where the number of
times cited is called the frequency or strength of co-words
[35]. “Cluster analysis” is a collective term covering a wide
variety of techniques for delineating natural groups or clus-
ters in data sets [36]. The task of it is to group a set of ob-
jects in such a way that objects in the same group (called
clusters) are more similar to each other than to those in
other cluster groups. It was used in many fields, including
machine learning, pattern recognition, image analysis, in-
formation retrieval, and bioinformatics [37,38]. In this
study, co-author, co-word, and cluster analysis methods
were used to analyze the collaboration among several re-
search organizations through visualization technology,
which was also called knowledge mapping technology
[39,40]. Knowledge mapping contain scientific data gather-
ing, surveying, exploring, discovery, conversation, disagree-
ment, gap analysis, education and synthesis technologies. It
aims to track the loss and acquisition of information &
knowledge, personal and group competencies and profi-
ciencies, show knowledge flows, appreciate the influence
on intellectual capital due to staff loss, assist with team se-
lection and technology matching. The map of the keywords
can forecast the future trend of a science subject well [41].
Results and discussion
Figures and tables were employed to describe the pro-
duction and future trends of translational medical
Yao et al. BMC Medical Informatics and Decision Making 2013, 13:77 Page 5 of 15
http://www.biomedcentral.com/1472-6947/13/77research. Papers from the WoS database were studied
carefully using bibliometric analysis.
There are 5,500 total translational medical research-
related papers in the WoS database, including 16 docu-
ment types. Following the conventions used in other
bibliometric studies, we restrict further analysis to arti-
cles, which are peer-reviewed and represent original sci-
entific development. Publications of all other types are
thus removed from the analysis for the rest of this art-
icle. As for the publishing language, 3,197 or 97.9% of
the 3,267 journal articles are written in English. These
figures confirm that English is the prevalent academic
language, and most SCI and SSCI indexed journals are
published in English.
Global publication trend
The trend of annual papers in translational medical re-
search from 1993 to 2012 is shown in Figure 1. During
the past two decades WoS (including SCI, SSCI and
CPCI) papers on translational medical research pro-
duced ranged from five in 1993 to approximately 1,500
in 2011. WoS annual number of publications has grown
exponentially, especially after 2001, indicating that the
research has recently garnered more attention. It can be
seen from Figure 1. that not many researchers pay atten-
tion to the translational medical research before 2001,
and only a few papers were published. After 2006, the
number of SCI papers rapidly increased and reached its
production peak in 2011. The number of CPCI papers
started to decrease from 2009, while the number of SSCI
papers increased slowly during the last two decades.
Subjects of research papers
The top six subject categories based on the Journal Cit-
ation Report (JCR) are shown in Figure 2. They are all
branches of medical science. Figure 2. also shows that




































Figure 1 Research papers published from 1993 to 2012.fields of basic clinical science (including Research & Ex-
perimental Medicine, Medical Laboratory Technology)
and clinical medical science (including General & In-
ternal Medicine, Oncology, Neurosciences & Neur-
ology), where Pharmacology & Pharmacy also play an
important role. In addition, more studies have focused
on public health science, including Public, Environmen-
tal & Occupational Health and Health Care Sciences &
Services, wherein investigators study factors and inter-
ventions that influence the health of populations to im-
prove public and global health. Figure 2. shows that
public health research had become an important part of
translational medical research.
To represent more synthetically the relations between
categories, the subjects’ categories co-occurrence network
was drawn and visualized in Figure 3. In this network
map, the centrality of a node representing a subject cat-
egory is a graph-theoretical property that quantifies the
importance of the node’s position in a network. Figure 3
shows that in the scientific network map of translational
medical research, the centrality of the terms “Research &
Experimental Medicine”, “Medical Laboratory Technol-
ogy”, “General & Internal Medicine” is outstanding. Mean-
while, the position of “Oncology”, “Neurosciences &
Neurology”, “Pharmacology & Pharmacy”, “Cell Biology”
“Biochemistry & Molecular Biology”, “Immunology” are
very important. These subjects play a key role in transla-
tional medical research.Journals of publication
The top 11 journals with more than 25 articles are
displayed in Table 1. Approximately 23% of WoS papers
resided in these most productive top 11 journals, which
are considered the core journals of translational medical
research area under Bradford Law [42]. The remaining










































Figure 2 Main subjects of WoS papers on translational
medical research.
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Figure 4. It can be seen that the Translational Research
and Science Translational Medicine published numerous
articles from 2007 to 2011. Translational Research, one of
journals supported by the CTSA, was renamed from the
Journal of Laboratory and Clinical Medicine in 2006.
Science Translational Medicine had a drastic increase in
article publication during this period. However, publication
of other journals increased slowly while its growth rate
remained. According to these trends it may be possible
that Translational Research, CTS, and Science Transla-
tional Medicine will be the primary journals for transla-
tional medical research publication in coming years.
Countries of publication
Top countries of publication of these papers are noted
in Table 2. There were 74 countries/territories producing
WoS papers on translational medical research over the
investigation period. Among them, only nine countries
had article output during the 1992–2001 timeframe, and
65 countries/territories had just began to publish papers
after 2001. The top 10 countries/territories were rankedFigure 3 Subjects categories co-occurrence network.by number of articles (Table 2). Two North and Central
American countries, six European countries, and two
Asian countries/territories were ranked in the top 10 for
WoS papers published. There are no African countries
in the top 10. The seven major industrialized nations of
the world (G7 countries [2] ), the USA, UK, Germany,
Canada, Italy Japan, and France, were the top seven
countries for publication. The pattern of domination in
publication of the G7 countries has occurred in most
scientific fields [43]. It reflects the high economic activ-
ity and academic level of these countries [44]. The USA
had the greatest contribution with 2,752 papers. WoS
publications from UK, Germany, Canada, Italy, and
Japan are 466, 333, 307 266, and 205 respectively. The
number of publications from other countries was below
200. Japan was the sixth most-active country according
to the total papers published. The top two productive
countries carried out most of the international collabo-
rations with others in the translational medical research
field (see Table 2).
Figure 5 shows the published papers of the most pro-
ductive countries during the period of this study. It can
be concluded that translational medical research started
in most countries in the 1990s and increased after 2005.
The USA began its translational medical research earlier
and kept rapidly increasing paper production. Compared
with UK, Germany started earlier but dropped behind
thereafter. The USA was the leading country during last
decade, where papers published from 2000–2011 in-
creased dramatically from 11 to 518 during the last dec-
ade. It can be said that translational medical research is
still a hot field in today’s world and is likely to continue
in popularity.
The top countries’ paper citations are noted in Figure 6.
It shows information about the total citation and citation
frequencies of the research papers from the top countries
Table 1 Basic information of top productive journals
No Journal Records Country IF1 (2012)
1 Translational Research 323 USA 3.490
2 Science Translational Medicine 86 USA 10.757
3 CTS-Clinical and Translational Science 65 USA 2.330
4 Journal of Translational Medicine 48 England 3.459
5 Journal of Investigative Medicine 37 USA 1.746
6 Clinical Cancer Research 35 USA 7.837
7 Diabetes Care 34 USA 7.735
8 Academic Medicine 34 USA 3.292
9 European Journal of Cancer 33 England 5.061
10 PLoS One 27 USA 3.730
10 Annals of Oncology 27 England 7.384
1 IF is impact factor, devised by Eugene Garfield, is calculated yearly starting from 1975 for those journals that are indexed in the Journal Citation Reports. The
impact factor (IF) of an academic journal is a measure reflecting the average number of citations for recent articles published in the journal. It is frequently used
as a proxy for the relative importance of a journal within its field, journals with higher impact factors deemed to be more important than those with lower ones.
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be seen that the total citation count of the USA is highest,
followed by UK, Germany, Canada and Italy in turn. The
average citation frequency, sorted in descending order, is
Canada, Italy and the USA. The USA and UK are on the
front ranks except for average citation frequency, showing
their superiority in translational medical research. Canada
ranks fourth in issued number of papers and first in article
citation frequency, which indicates the high average qual-
ity of the papers. Japan and China rank sixth and ninth re-
spectively in issued volumes with lower article citation
frequencies, which may indicate that there is a consider-
able problem with the quality of Japanese and Chinese pa-
pers issued.
Institutes of publication
The contribution of different institutes was assessed by
the institute of the affiliation with at least one author in
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Figure 4 Annual journals distribution of WoS papers.quantity of more than 50 were ranked by their published
papers. According to Figure 7, Harvard University and
the University of Pittsburgh performed well: they are
two of the most powerful institutions in translational
medicine research. Harvard University published 146 pa-
pers, ranking first and followed by the University of
Pittsburgh with 90 papers. It can be seen that the total
citation count from Harvard University is the highest,
followed by Stanford University and the University of
California Los Angeles. Harvard University was the lead-
ing institute both in paper quantity and quality. All the
organizations belong to the United States; reflecting the
overall strength of the U.S. universities.
Citation of research papers
The number of citations does not necessarily indicate
the quality of a paper, but it is a measure of its impact
and/or visibility in translational medical research field.












Table 2 Publication distribution in top countries
Country2 USA UK Germany Canada Italy Japan France P.R China Netherlands Spain
Records 2752 466 333 307 266 205 160 158 157 152
Percentage 53.74 9.09 6.50 6.00 5.20 4.00 3.12 3.09 3.06 2.97
2 The G7, as a group consisting of the finance ministers of seven industrialized nations: the U.S., U.K., France, Germany, Italy, Canada and Japan, is seven of the
eight (China excluded) wealthiest nations on Earth, not by GDP but also by global net wealth.
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frequently cited article was “The Meaning of Transla-
tional Research and why it Matters,” published in 2008
by S. H. Woolf. It has been cited 111 times since it was
published in the JAMA, which vastly exceeds the citation
of the others articles on the translational medical re-
search field. E. A. Zerhouni, at the National Institutes of
Health contributed the highest number (No. 3 and 4) of
articles among the 10 most frequently cited articles,
which exhibits its predominance. These top cited papers
were all authored by scientists from institutions in devel-
oped countries. The USA contributed ten and the
Netherlands contributed one.
Table 3 also shows that most articles focused on the
meaning and importance of translational medical re-
search, and highlights the “NIH roadmap” and CTSAs.
The NIH Roadmap is a set of bold initiatives aimed at
accelerating medical research that addresses challenges
that no single NIH institute could tackle alone, but the
agency as a whole must undertake. The Roadmap identi-
fies the most compelling opportunities in three arenas:
new pathways to discovery, research teams of the future,
and reengineering the clinical research enterprise. As
early as 2006, the NIH made translational research a pri-
ority, forming centers of translational research at its in-
stitutes and launching the Clinical and Translational
Science Award (CTSA) program. By 2012, the NIH had
founded 60 research centers with a budget of $500 mil-
lion per year. Besides academic centers, foundations, in-































Figure 5 Annual WoS publications distribution of top 10 countries.and health systems have also established translational re-
search programs, and at least two journals (Transla-
tional Medicine and the Journal of Translational
Mdicine) are devoted to the topic. Other most frequently
cited articles prove that researchers from around the
world have concentrated on translation research of bio-
markers, genomics gene-expression for health care and
disease prevention. From the data it can be concluded
that the translational medical research trend will focus
on basic medicine, clinical medicine, and public health.
Authorship and co-authorship
Owing to the specialization of research activities of each
nation, international collaboration could be effective in
promoting the creation, transmission, and sharing of
knowledge, and in posing a serious obstacle to the diverse
types of collective, exchangeable, and integrated know-
ledge [45]. Increasing globalization may lead to the in-
crease of international collaboration in science and
technology. The national cooperative network map of
translational medical research has been drawn according
to the national/regional cooperation data. As shown in
Figure 8, a total network of higher density illustrates closer
cooperation between countries. The USA, UK and Canada
cooperate frequently with other countries/regions and
stand at the core position of the entire network, which in
turn benefits from their knowledge transfer among trans-
lational medical researchers. The USA, which has issued
the most volumes, and other nations such as Australia,





























Total Citations Average Citations
Publish Year
Figure 6 Citations of WoS papers for top 10 countries.
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layer. Other countries/regions such as Taiwan and Brazil
have had less cooperation with other regions/countries, so
they are in the outermost layer of the entire cooperation
network.
Collaboration within one organization is found to
be as high as 41.49%. Collaboration with authors from
more than one institute is in the majority, which covers
more than one half of the figures. From this data, it can
be concluded that collaboration between institutes is in
the mainstream of translational medical research. The
cooperative network map of organizations in transla-
tional medical research is also drawn according to the
cooperation between institutions. The American insti-
tutes of Harvard University, the University of Michigan,
the University of California Los Angeles, and Indiana
University are in the core status of the network; these
institutions cooperate with other organizations fre-
quently, thus playing an important role in the process of
knowledge transfer among organizations. Other high-




































































Figure 7 The institutes distribution of WoS papers.McGill University, and the University of British
Columbia are at the edge of the network due to their
less cooperation. It can be concluded that American in-
stitutions have made great advances in paper production
and cooperation, with great strength and good develop-
ment prospects. The annual count of authored papers is
noted in Figure 9.
As shown in Figure 10, most work on the translational
medical research was done by one to five researchers,
most notably by one scientist, a mainstream trend of all
research activity. Some of the translational medical re-
search studies were the results of collaboration by more
than five authors. This level of collaboration between
scientists or their institutes is indeed the trend of mod-
ern research activity. Most translational medical research
was done by the collaboration of several scientists. It can
be seen from Figure 10. That the one to three scientists’
teams increased rapidly after 2005, while five-person or
four-person teams increased quickly, but were not as
steady compared to others. Convenient modern commu-
nications make these collaborations possible. Single au-
thor articles increased from 2000 to 2005 in linear
expansion, but didn’t increase as fast as papers published
by a few co-authors after 2005. The analysis indicates
that collaboration is not only possible but necessary for
the translational medical research.
Keywords and co-words
The technique of statistical analysis of keywords and
title-words may indicate directions of research. Espe-
cially, authors’ keywords analysis could offer information
on research trends as viewed by researchers [19]. The
high percentage of once-only author keywords probably
indicates a lack of continuity in research and a wide dis-
parity in research focuses. Another reason is that these



















































Table 3 Top 10 most cited WOS papers
No. Time cited Authors Title Journal Institute Country Year
1 111 Woolf Steven H. The meaning of translational research and why
it matters
JAMA Virginia Commonwealth University USA 2008
2 102 Sung, NS; Crowley,
WF; Genel, M; et al.
Central challenges facing the national clinical research
enterprise
JAMA Burroughs Wellcome Fund USA 2003
3 66 Zerhouni, EA Translational and clinical science - Time for a new vision New EnglandJournal
of Medicine
National Institutes of Health USA 2005
4 65 Zerhouni, EA The NIH roadmap Science National Institutes of Health USA 2003
5 60 Westfall, JM; Mold,
J; Fagnan, L
Practice-based research - “Blue Highways” on the
NIH roadmap
JAMA University of Colorado Health Sciences
Center
USA 2007
6 53 Hanahan, D; Weinberg, RA The hallmarks of cancer Cell University of California, San Francisco USA 2000
7 46 van de Vijver, MJ; He,
YD; van ’t Veer, LJ; et al.




Netherlands Cancer Institute Netherlands 2002
8 44 Marincola FM Translational medical research: A two-way road Journal of Translational
medical research
National Institutes of Health USA 2003
9 41 Khoury, MJ; Gwinn, M; Yoon,
PW; et al.
The continuum of translation research in genomic medicine:
how can we accelerate the appropriate integration of human
genome discoveries into health care and disease prevention?
Genetics in Medicine National Office of Public Health Genomics
Centers for Disease Control and Prevention
USA 2007
10 40 van’t Veer, LJ; Dai, HY;
van de Vijver, MJ; et al.
Gene expression profiling predicts clinical outcome of
breast cancer
Nature Rosetta Inpharmat, Kirkland USA 2002
10 40 Paez, JG; Janne, PA;
Lee, JC; et al.
EGFR mutations in lung cancer: Correlation with clinical
response to gefitinib therapy
Science Departments of Medical Oncology and

























Figure 8 Co-authorship for WoS publications in different countries.
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http://www.biomedcentral.com/1472-6947/13/77researchers. Author keywords appearing in the articles re-
ferring to translational medical research from 1993 to 2012
were calculated and ranked. The top eight author keywords
used and distribution during the last 20 years are displayed
in Figure 11, where research variations can be roughly
grasped. Except for “translational research,” and “transla-
tional medicine” which were search words, the top six most
frequently used keywords were “biomarkers”, “stroke”, “in-
flammation”, “cancer”, “biomarker”, and “breast cancer.”
Figure 11 shows the most frequently used author key-
words distributed from 2000 to 2012. During the past dec-
ade the keyword “translational research” rose from only
several times mentioned to more than 100 times, there by
becoming the most dominant keyword used in the study.
Other than “translational medicine,” “biomarkers”, “in-
flammation”, “cancer”, “biomarker”, and “breast cancer.”
had high increasing rates. These figures reveal that “bio-
marker/ biomarkers” are hot topics in translational med-
ical research throughout the world, and are of serious
concern to researchers. Biomarker and cancer research
may thus play important roles in translational medicalFigure 9 Co-authorship for WoS publications in different institutes.research science in the future. Otherwise, researchers are
making progress across a broad range of diseases and con-
ditions, such as cancer (especially breast cancer), diabetes,
neurological disorders, and heart disease, which are the
main application fields of translational medical research.
The title of an article has the core information that au-
thors would like to express [46]. Meanwhile, author key-
word analysis offers information about research trends
from the view of researchers, and has proved to be im-
portant for monitoring the development of science [47].
Keywords Plus supplied additional search terms extracted
from the titles of articles cited by authors in their bibliog-
raphies and footnotes [48]. The topic of papers can be
obtained from the title-words, author keywords, and key-
words plus by cluster analysis. Clusters or co-words maps
of papers could image the core competency of the transla-
tional medical research. Figure 12 is derived from biblio-
metric analysis on the papers of translational medical
research in WoS by Aureka software. It can be seen that
these topics listed below are topics in translational medical
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Figure 10 Annual number of authors of WoS papers.
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http://www.biomedcentral.com/1472-6947/13/77treatment of disease (such as cancer, acute stroke, cardiac
disease, disorders, stress disease, and diabetes), disease
model research, evidence-based research (such as guide-
line practice and nurse practice), stem and progenitor
cells, immunity and vaccine, biomarkers, training and car-
eer development of scientists, fostering collaborations and
research teams, and public health science.
Figure 13 shows the clusters of the top 60 most-used
MeSH terms in the 20 years. The most frequently used
keyword was “Translational Medical Research” as it was
the string used for searching in this study. Similarly with
the cluster results of title-words, author keywords and key-
words plus from WoS, “drug design/drug discovery”, “anti-
neoplastic agents”; “neoplasms”, “medical oncology”, “lung
neoplasms, carcinoma/non-small-cell lung”, “brain neo-
plasms”, “prostatic neoplasms”, “tumor markers/bio-
logical”; “biological markers”; “immunotherapy”, “heart
failure”, “cardiovascular diseases”; “stem cell transplant-
ation, stem cells”, and “evidence-based medicine, medical
















Figure 11 Timeframes of keywords in the period of 2001–2011.Topic (Figure 13). Besides, the MeSH Major Topic related
to neoplasms diseases such as “proteomics”, “gene expres-
sion profiling”, “gene therapy”, and “research design” were
given more attention during the last 20 years, which
showed that they may be new methods used to treat cancer
and other diseases. Furthermore, “diagnostic imaging”,
“obesity”, “delivery of health care”, “biomedical research,
diffusion of innovation, interdisciplinary communication”
and “National Institutes of Health (U.S),research support
as topic, awards and prizes”, which did not appear in Fig-
ure 13, also showed a hot topics in translational medical
research fields.
Conclusion
This study summarized some significant research trends
and performance in worldwide translational medicine.
The articles on translational medicine increased rapidly
during the last 20 years. Translational medical research
articles were mainly located in the fields of Research &
Experimental Medicine, General & Internal Medicine,006 2007 2008 2009 2010 2011 2012
Figure 12 Clusters and Co-words Map of WoS papers.
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http://www.biomedcentral.com/1472-6947/13/77Oncology, Neurosciences & Neurology, Medical Labora-
tory Technology, and Pharmacology & Pharmacy. Mean-
while, “Research & Experimental Medicine”, “Medical
Laboratory Technology”, and “General & Internal Medi-
cine” play a key role in translational medical research
subjects categories co-occurrence network. Moreover,
more attention was paid to Public, Environmental & Oc-
cupational health and Health Care Sciences & Services
in recent years. It is clear that translational medicine will
be a focus in the public health field besides basic clinical
science and clinical medical science in future. The top
three most productive journals, which are Translational
Research (323), Science Translational Medicine (86) and
CTS (65), published approximately 14.5% of WoS papers.
Especially Translational Research, renamed from theFigure 13 Clusters and Co-words Map of PubMed papers.Journal of Laboratory and Clinical Medicine, was the
chief journal for the translational medicine research in
last three years. Meanwhile, Science Translational Medi-
cine, as sub journal of Science, has the highest impact
factor among translational medical research journals. The
G7 countries, the USA, UK, Germany, Canada, Italy,
Japan, and France, are the leaders of translational medical
research. The USA and the institutions of America play a
dominant role in the production, collaboration, citation
and high quality articles. In the perspective of collabor-
ation, the research papers were mainly completed by one
to five authors, and Multi-authors comprised a larger
percentage.
Except for “translational research” and “translational
medicine”, the terms most frequently used in the last
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http://www.biomedcentral.com/1472-6947/13/77decades of research were “biomarker”, “stroke”, “cancer”
and “breast cancer”. This suggests that “biomarker” and
“genomics” in disease research and application (such as
cancer, diabetes, etc.) are the mainstream topics in the
study field. Analyzing the keywords distribution trends
shown, it can be assumed that translational research will
attract more research interest. Recent major topics of
translational medical research included drug design and
development, pathogenesis and treatment of disease, dis-
ease model research, evidence-based research, stem &
progenitor cells, immunity & vaccine, biomarkers, training
and career development of scientists, fostering collabora-
tions. Besides, the translation among clinical medical sci-
ence, basic clinical science, and public and health science
may be new research direction, especially the T3 (Efficacy.
Potential clinical application (theoretical knowledge) to
evidence-based guidelines (efficacy knowledge)) and T4
(Clinical care or intervention (applied knowledge) to the
health of a community or population (public health know-
ledge)) researches. The findings of this study can help sci-
entific researchers understand the performance and
central trends of translational medical research globally
and therefore suggest directions for further research.
Limitations
Relevant articles were extracted using text-supplied key-
words from the National Library of Medicine’s Medical
Subject Headings thesaurus. In order to improve the two
criteria, papers in journals whose name contains “translat*”
are also included, and the papers which do not belong to
medicine-related subjects are excluded. However, the bene-
fits of using bibliometric search terms are debatable. The
identification of the appropriate terms identifying transla-
tional medical research may be a matter for further studies.
Due to limited resources and research levels, this study only
searched sound articles in the Web of Knowledge and
PubMed, which content has certain limitations. Moreover,
methods of social network analysis and visualization tech-
nologies are relatively fresh perspective but lacking
innovation for its newly application in this field. In addition,
the lacking of regularity in the key word (extracting 20%
keywords according to the law of two to eight) and mesh
term selection also impacts the analysis process and results.
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